Ueki H, Jimbo N, Terakawa T, Hara T, et al. Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53. Prostate 2024 Sep 15. doi: 10.1002/pros.24791.
PMID: 39279246